nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Nervous system disorder—Thiotepa—sarcoma	0.00292	0.00292	CcSEcCtD
Remifentanil—Thrombocytopenia—Thiotepa—sarcoma	0.00292	0.00292	CcSEcCtD
Remifentanil—Anaemia—Mitoxantrone—sarcoma	0.00292	0.00292	CcSEcCtD
Remifentanil—Tachycardia—Thiotepa—sarcoma	0.00291	0.00291	CcSEcCtD
Remifentanil—Thrombocytopenia—Dactinomycin—sarcoma	0.0029	0.0029	CcSEcCtD
Remifentanil—Skin disorder—Thiotepa—sarcoma	0.0029	0.0029	CcSEcCtD
Remifentanil—Convulsion—Vincristine—sarcoma	0.00281	0.00281	CcSEcCtD
Remifentanil—Flushing—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Remifentanil—Cardiac disorder—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Remifentanil—Hypertension—Vincristine—sarcoma	0.0028	0.0028	CcSEcCtD
Remifentanil—Hepatic function abnormal—Epirubicin—sarcoma	0.0028	0.0028	CcSEcCtD
Remifentanil—Pulmonary oedema—Doxorubicin—sarcoma	0.00277	0.00277	CcSEcCtD
Remifentanil—Cough—Mitoxantrone—sarcoma	0.00275	0.00275	CcSEcCtD
Remifentanil—Angiopathy—Etoposide—sarcoma	0.00274	0.00274	CcSEcCtD
Remifentanil—Convulsion—Mitoxantrone—sarcoma	0.00273	0.00273	CcSEcCtD
Remifentanil—Hypertension—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Remifentanil—Immune system disorder—Etoposide—sarcoma	0.00272	0.00272	CcSEcCtD
Remifentanil—Mediastinal disorder—Etoposide—sarcoma	0.00272	0.00272	CcSEcCtD
Remifentanil—Chills—Etoposide—sarcoma	0.00271	0.00271	CcSEcCtD
Remifentanil—Paraesthesia—Thiotepa—sarcoma	0.00268	0.00268	CcSEcCtD
Remifentanil—Anxiety—Mitoxantrone—sarcoma	0.00268	0.00268	CcSEcCtD
Remifentanil—Somnolence—Thiotepa—sarcoma	0.00265	0.00265	CcSEcCtD
Remifentanil—Anaphylactic shock—Vincristine—sarcoma	0.00264	0.00264	CcSEcCtD
Remifentanil—Oedema—Vincristine—sarcoma	0.00264	0.00264	CcSEcCtD
Remifentanil—Dyspepsia—Thiotepa—sarcoma	0.00263	0.00263	CcSEcCtD
Remifentanil—Confusional state—Mitoxantrone—sarcoma	0.0026	0.0026	CcSEcCtD
Remifentanil—Nervous system disorder—Vincristine—sarcoma	0.00259	0.00259	CcSEcCtD
Remifentanil—Thrombocytopenia—Vincristine—sarcoma	0.00259	0.00259	CcSEcCtD
Remifentanil—Hepatic function abnormal—Doxorubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Remifentanil—Anaphylactic shock—Mitoxantrone—sarcoma	0.00258	0.00258	CcSEcCtD
Remifentanil—Oedema—Mitoxantrone—sarcoma	0.00258	0.00258	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Thiotepa—sarcoma	0.00258	0.00258	CcSEcCtD
Remifentanil—Renal impairment—Epirubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Remifentanil—Hyperhidrosis—Vincristine—sarcoma	0.00256	0.00256	CcSEcCtD
Remifentanil—Pain—Thiotepa—sarcoma	0.00255	0.00255	CcSEcCtD
Remifentanil—Constipation—Thiotepa—sarcoma	0.00255	0.00255	CcSEcCtD
Remifentanil—Shock—Mitoxantrone—sarcoma	0.00253	0.00253	CcSEcCtD
Remifentanil—Pain—Dactinomycin—sarcoma	0.00253	0.00253	CcSEcCtD
Remifentanil—Thrombocytopenia—Mitoxantrone—sarcoma	0.00252	0.00252	CcSEcCtD
Remifentanil—Tachycardia—Mitoxantrone—sarcoma	0.00251	0.00251	CcSEcCtD
Remifentanil—Skin disorder—Mitoxantrone—sarcoma	0.0025	0.0025	CcSEcCtD
Remifentanil—Hyperhidrosis—Mitoxantrone—sarcoma	0.00249	0.00249	CcSEcCtD
Remifentanil—Hypotension—Vincristine—sarcoma	0.00247	0.00247	CcSEcCtD
Remifentanil—Feeling abnormal—Thiotepa—sarcoma	0.00246	0.00246	CcSEcCtD
Remifentanil—Feeling abnormal—Dactinomycin—sarcoma	0.00244	0.00244	CcSEcCtD
Remifentanil—Anaemia—Etoposide—sarcoma	0.00243	0.00243	CcSEcCtD
Remifentanil—Hypotension—Mitoxantrone—sarcoma	0.00241	0.00241	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Remifentanil—Paraesthesia—Vincristine—sarcoma	0.00237	0.00237	CcSEcCtD
Remifentanil—Urticaria—Thiotepa—sarcoma	0.00237	0.00237	CcSEcCtD
Remifentanil—Body temperature increased—Thiotepa—sarcoma	0.00236	0.00236	CcSEcCtD
Remifentanil—Body temperature increased—Dactinomycin—sarcoma	0.00234	0.00234	CcSEcCtD
Remifentanil—Cardiac arrest—Epirubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Remifentanil—Paraesthesia—Mitoxantrone—sarcoma	0.00231	0.00231	CcSEcCtD
Remifentanil—Loss of consciousness—Etoposide—sarcoma	0.00231	0.00231	CcSEcCtD
Remifentanil—Dyspnoea—Mitoxantrone—sarcoma	0.0023	0.0023	CcSEcCtD
Remifentanil—Cough—Etoposide—sarcoma	0.00229	0.00229	CcSEcCtD
Remifentanil—Somnolence—Mitoxantrone—sarcoma	0.00229	0.00229	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Vincristine—sarcoma	0.00228	0.00228	CcSEcCtD
Remifentanil—Convulsion—Etoposide—sarcoma	0.00227	0.00227	CcSEcCtD
Remifentanil—Dyspepsia—Mitoxantrone—sarcoma	0.00227	0.00227	CcSEcCtD
Remifentanil—Hypertension—Etoposide—sarcoma	0.00227	0.00227	CcSEcCtD
Remifentanil—Pain—Vincristine—sarcoma	0.00226	0.00226	CcSEcCtD
Remifentanil—Constipation—Vincristine—sarcoma	0.00226	0.00226	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00222	0.00222	CcSEcCtD
Remifentanil—Pain—Mitoxantrone—sarcoma	0.0022	0.0022	CcSEcCtD
Remifentanil—Constipation—Mitoxantrone—sarcoma	0.0022	0.0022	CcSEcCtD
Remifentanil—Hypersensitivity—Thiotepa—sarcoma	0.0022	0.0022	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—sarcoma	0.00219	0.00219	CcSEcCtD
Remifentanil—Hypersensitivity—Dactinomycin—sarcoma	0.00218	0.00218	CcSEcCtD
Remifentanil—Confusional state—Etoposide—sarcoma	0.00216	0.00216	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Remifentanil—Anaphylactic shock—Etoposide—sarcoma	0.00214	0.00214	CcSEcCtD
Remifentanil—Feeling abnormal—Mitoxantrone—sarcoma	0.00212	0.00212	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Remifentanil—Pruritus—Thiotepa—sarcoma	0.00211	0.00211	CcSEcCtD
Remifentanil—Thrombocytopenia—Etoposide—sarcoma	0.0021	0.0021	CcSEcCtD
Remifentanil—Tachycardia—Etoposide—sarcoma	0.00209	0.00209	CcSEcCtD
Remifentanil—Body temperature increased—Vincristine—sarcoma	0.00209	0.00209	CcSEcCtD
Remifentanil—Skin disorder—Etoposide—sarcoma	0.00208	0.00208	CcSEcCtD
Remifentanil—Hyperhidrosis—Etoposide—sarcoma	0.00207	0.00207	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Remifentanil—Urticaria—Mitoxantrone—sarcoma	0.00205	0.00205	CcSEcCtD
Remifentanil—Diarrhoea—Thiotepa—sarcoma	0.00204	0.00204	CcSEcCtD
Remifentanil—Body temperature increased—Mitoxantrone—sarcoma	0.00204	0.00204	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Remifentanil—Diarrhoea—Dactinomycin—sarcoma	0.00203	0.00203	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Remifentanil—Hypotension—Etoposide—sarcoma	0.002	0.002	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Remifentanil—Dizziness—Thiotepa—sarcoma	0.00197	0.00197	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Remifentanil—Hypersensitivity—Vincristine—sarcoma	0.00195	0.00195	CcSEcCtD
Remifentanil—Paraesthesia—Etoposide—sarcoma	0.00192	0.00192	CcSEcCtD
Remifentanil—Dyspnoea—Etoposide—sarcoma	0.00191	0.00191	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Remifentanil—Somnolence—Etoposide—sarcoma	0.0019	0.0019	CcSEcCtD
Remifentanil—Hypersensitivity—Mitoxantrone—sarcoma	0.0019	0.0019	CcSEcCtD
Remifentanil—Vomiting—Thiotepa—sarcoma	0.0019	0.0019	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Remifentanil—Vomiting—Dactinomycin—sarcoma	0.00188	0.00188	CcSEcCtD
Remifentanil—Rash—Thiotepa—sarcoma	0.00188	0.00188	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Remifentanil—Dermatitis—Thiotepa—sarcoma	0.00188	0.00188	CcSEcCtD
Remifentanil—Headache—Thiotepa—sarcoma	0.00187	0.00187	CcSEcCtD
Remifentanil—Rash—Dactinomycin—sarcoma	0.00187	0.00187	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Remifentanil—Constipation—Etoposide—sarcoma	0.00183	0.00183	CcSEcCtD
Remifentanil—Pain—Etoposide—sarcoma	0.00183	0.00183	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Remifentanil—Diarrhoea—Vincristine—sarcoma	0.00181	0.00181	CcSEcCtD
Remifentanil—Sweating—Epirubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Remifentanil—Nausea—Thiotepa—sarcoma	0.00177	0.00177	CcSEcCtD
Remifentanil—Feeling abnormal—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Remifentanil—Diarrhoea—Mitoxantrone—sarcoma	0.00176	0.00176	CcSEcCtD
Remifentanil—Nausea—Dactinomycin—sarcoma	0.00176	0.00176	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Remifentanil—Dizziness—Vincristine—sarcoma	0.00175	0.00175	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Remifentanil—Urticaria—Etoposide—sarcoma	0.0017	0.0017	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Remifentanil—Body temperature increased—Etoposide—sarcoma	0.00169	0.00169	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Remifentanil—Vomiting—Vincristine—sarcoma	0.00168	0.00168	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Remifentanil—Rash—Vincristine—sarcoma	0.00167	0.00167	CcSEcCtD
Remifentanil—Dermatitis—Vincristine—sarcoma	0.00167	0.00167	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Remifentanil—Headache—Vincristine—sarcoma	0.00166	0.00166	CcSEcCtD
Remifentanil—Vomiting—Mitoxantrone—sarcoma	0.00164	0.00164	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Remifentanil—Rash—Mitoxantrone—sarcoma	0.00162	0.00162	CcSEcCtD
Remifentanil—Dermatitis—Mitoxantrone—sarcoma	0.00162	0.00162	CcSEcCtD
Remifentanil—Headache—Mitoxantrone—sarcoma	0.00161	0.00161	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Remifentanil—Hypersensitivity—Etoposide—sarcoma	0.00158	0.00158	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Remifentanil—Nausea—Vincristine—sarcoma	0.00157	0.00157	CcSEcCtD
Remifentanil—Flushing—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Remifentanil—Nausea—Mitoxantrone—sarcoma	0.00153	0.00153	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Remifentanil—Chills—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Remifentanil—Pruritus—Etoposide—sarcoma	0.00152	0.00152	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Remifentanil—Erythema—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Remifentanil—Diarrhoea—Etoposide—sarcoma	0.00147	0.00147	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Remifentanil—Dizziness—Etoposide—sarcoma	0.00142	0.00142	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Remifentanil—Chills—Doxorubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Remifentanil—Vomiting—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Remifentanil—Agitation—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Remifentanil—Rash—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Remifentanil—Dermatitis—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Remifentanil—Headache—Etoposide—sarcoma	0.00134	0.00134	CcSEcCtD
Remifentanil—Syncope—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Remifentanil—Cough—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Remifentanil—Nausea—Etoposide—sarcoma	0.00127	0.00127	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Remifentanil—Oedema—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Remifentanil—Cough—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Remifentanil—Shock—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Remifentanil—Shock—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Remifentanil—Pain—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Remifentanil—Constipation—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—sarcoma	0.000998	0.000998	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—sarcoma	0.000991	0.000991	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—sarcoma	0.00099	0.00099	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—sarcoma	0.000988	0.000988	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000959	0.000959	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—sarcoma	0.000954	0.000954	CcSEcCtD
Remifentanil—Pain—Doxorubicin—sarcoma	0.00095	0.00095	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—sarcoma	0.00095	0.00095	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—sarcoma	0.000949	0.000949	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—sarcoma	0.000916	0.000916	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—sarcoma	0.000885	0.000885	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—sarcoma	0.000883	0.000883	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—sarcoma	0.000878	0.000878	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—sarcoma	0.00085	0.00085	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—sarcoma	0.000822	0.000822	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—sarcoma	0.000819	0.000819	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—sarcoma	0.000794	0.000794	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—sarcoma	0.000786	0.000786	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—sarcoma	0.000764	0.000764	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—sarcoma	0.00076	0.00076	CcSEcCtD
Remifentanil—Rash—Epirubicin—sarcoma	0.000757	0.000757	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—sarcoma	0.000757	0.000757	CcSEcCtD
Remifentanil—Headache—Epirubicin—sarcoma	0.000752	0.000752	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—sarcoma	0.000735	0.000735	CcSEcCtD
Remifentanil—Nausea—Epirubicin—sarcoma	0.000713	0.000713	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—sarcoma	0.000707	0.000707	CcSEcCtD
Remifentanil—Rash—Doxorubicin—sarcoma	0.000701	0.000701	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—sarcoma	0.0007	0.0007	CcSEcCtD
Remifentanil—Headache—Doxorubicin—sarcoma	0.000696	0.000696	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—sarcoma	0.00066	0.00066	CcSEcCtD
